Gilead Sciences

Country
USA
Краткое название
Gilead Sciences
Headquarters
333 Lakeside Drive
Members of the board

John C. Martin, PhD — Chairman and Chief Executive Officer
John F. Milligan, PhD — President and Chief Operating Officer
Norbert W. Bischofberger, PhD — Executive Vice President, Research and Development and Chief Scientific Officer
Gregg H. Alton — Executive Vice President, Corporate and Medical Affairs
Kevin Young CBE — Executive Vice President, Commercial Operations
Robin L. Washington — Senior Vice President and Chief Financial Officer

Categories medicine
Cardiology, Infectious diseases, Endocrinology
Stage of the project
Production
Disease
Mucoviscidosis, HIV, Viral hepatitis, Ischemic heart disease
Ticker
GILD
Current owners

John C. Martin, PhD — Chairman and Chief Executive Officer, Gilead Sciences
James M. Denny — Lead Independent Director, Gilead Sciences Board of Directors
John F. Cogan, PhD — Senior Fellow, Hoover Institution, Stanford University
Etienne F. Davignon — Minister of State Chairman, Genfina
Carla A. Hills — Chair and Chief Executive Officer, Hills & Company, International Consultants
Kevin E. Lofton — President and Chief Executive Officer, Catholic Health Initiatives
John W. Madigan — Retired Chairman and Chief Executive Officer, Tribune Company
Gordon E. Moore, PhD — Retired Chairman and Chief Executive Officer, Intel Corporation
Nicholas G. Moore — Retired Global Chairman, PricewaterhouseCoopers
Richard J. Whitley, MD — Distinguished Professor, Loeb Scholar Chair in Pediatrics, Professor of Pediatrics, Microbiology, Medicine, and Neurosurgery, University of Alabama at Birmingham
Gayle Edlund Wilson — Former Chair, Ralph M. Parsons Foundation
Per Wold-Olsen — Retired President, Human Health Intercontinental Division, Merck & Co., Inc.
George P. Shultz, PhD — Distinguished Fellow, Hoover Institution, Stanford University

Assets
179.3100
Technology
Technologies, Pharmaceuticals, Chemistry